InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by JOHN M EVANS. Director active across 1 company, notably Beam Therapeutics Inc.. In total, 2 reports have been published. History available since 29 June 2026. The latest transaction was disclosed on 30 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations